Commonwealth Equity Services
BSTG

Commonwealth Equity Services’s Biostage, Inc. Common Stock BSTG Stock Holding History

Commonwealth Equity Services’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,547
Closed -$5K – 2762
2017
Q3 		$5K Hold
14,547
– – ﹤0.01% 2564
2017
Q2 		$6K Hold
14,547
– – ﹤0.01% 2517
2017
Q1 		$5K Buy
14,547
+25
+0.2% +$14 ﹤0.01% 2412
2016
Q4 		$13K Buy
14,522
+3,000
+26% +$2.67K ﹤0.01% 2302
2016
Q3 		$12K Hold
11,522
– – ﹤0.01% 2234
2016
Q2 		$13K Buy
+11,522
New +$18.6K ﹤0.01% 2216

Commonwealth Equity Services's BSTG Position: Q4 2017 in Review

Commonwealth Equity Services sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 14,547 shares — an estimated $5K sold.

Commonwealth Equity Services first reported a position in BSTG in Q2 2016 and held it in 6 quarters. The position peaked at $13K in Q4 2016. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

  • Commonwealth Equity Services reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Commonwealth Equity Services sold 14,547 Biostage, Inc. Common Stock shares in Q4 2017, an estimated $5K.
  • Commonwealth Equity Services first reported a position in Biostage, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
  • Commonwealth Equity Services's Biostage, Inc. Common Stock position peaked at $13K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on Commonwealth Equity Services's 13F filing for Q4 2017, filed 12 Feb 2018.